BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
17,710
+30 (0.17%)
Jul 18, 2025, 3:30 PM KST
-5.09%
Market Cap547.67B
Revenue (ttm)140.13B
Net Income (ttm)-25.29B
Shares Out30.92M
EPS (ttm)-806.22
PE Ration/a
Forward PE51.32
Dividendn/a
Ex-Dividend Daten/a
Volume534,902
Average Volume422,637
Open17,800
Previous Close17,680
Day's Range17,560 - 18,130
52-Week Range12,800 - 27,300
Beta1.26
RSI59.67
Earnings DateAug 13, 2025

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 616
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.